PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BMEZ vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BMEZ and ARKG is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.6

Performance

BMEZ vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Health Sciences Trust II (BMEZ) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
9.63%
-3.09%
BMEZ
ARKG

Key characteristics

Sharpe Ratio

BMEZ:

1.33

ARKG:

-0.24

Sortino Ratio

BMEZ:

2.06

ARKG:

-0.07

Omega Ratio

BMEZ:

1.24

ARKG:

0.99

Calmar Ratio

BMEZ:

0.57

ARKG:

-0.12

Martin Ratio

BMEZ:

5.04

ARKG:

-0.44

Ulcer Index

BMEZ:

4.22%

ARKG:

21.96%

Daily Std Dev

BMEZ:

16.02%

ARKG:

41.05%

Max Drawdown

BMEZ:

-46.05%

ARKG:

-80.10%

Current Drawdown

BMEZ:

-23.19%

ARKG:

-76.77%

Returns By Period

In the year-to-date period, BMEZ achieves a 13.34% return, which is significantly higher than ARKG's 10.26% return.


BMEZ

YTD

13.34%

1M

10.72%

6M

9.63%

1Y

20.13%

5Y*

N/A

10Y*

N/A

ARKG

YTD

10.26%

1M

9.63%

6M

-3.10%

1Y

-12.94%

5Y*

-5.21%

10Y*

2.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BMEZ vs. ARKG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMEZ
The Risk-Adjusted Performance Rank of BMEZ is 7878
Overall Rank
The Sharpe Ratio Rank of BMEZ is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of BMEZ is 8181
Sortino Ratio Rank
The Omega Ratio Rank of BMEZ is 7676
Omega Ratio Rank
The Calmar Ratio Rank of BMEZ is 6969
Calmar Ratio Rank
The Martin Ratio Rank of BMEZ is 8181
Martin Ratio Rank

ARKG
The Risk-Adjusted Performance Rank of ARKG is 55
Overall Rank
The Sharpe Ratio Rank of ARKG is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKG is 66
Sortino Ratio Rank
The Omega Ratio Rank of ARKG is 66
Omega Ratio Rank
The Calmar Ratio Rank of ARKG is 44
Calmar Ratio Rank
The Martin Ratio Rank of ARKG is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BMEZ vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BMEZ, currently valued at 1.33, compared to the broader market-2.000.002.004.001.33-0.24
The chart of Sortino ratio for BMEZ, currently valued at 2.06, compared to the broader market-4.00-2.000.002.004.006.002.06-0.07
The chart of Omega ratio for BMEZ, currently valued at 1.24, compared to the broader market0.501.001.502.001.240.99
The chart of Calmar ratio for BMEZ, currently valued at 0.57, compared to the broader market0.002.004.006.000.57-0.12
The chart of Martin ratio for BMEZ, currently valued at 5.04, compared to the broader market0.0010.0020.0030.005.04-0.44
BMEZ
ARKG

The current BMEZ Sharpe Ratio is 1.33, which is higher than the ARKG Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of BMEZ and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
1.33
-0.24
BMEZ
ARKG

Dividends

BMEZ vs. ARKG - Dividend Comparison

BMEZ's dividend yield for the trailing twelve months is around 11.02%, while ARKG has not paid dividends to shareholders.


TTM20242023202220212020201920182017
BMEZ
BlackRock Health Sciences Trust II
11.02%11.74%10.81%11.28%6.75%3.14%0.00%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

BMEZ vs. ARKG - Drawdown Comparison

The maximum BMEZ drawdown since its inception was -46.05%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for BMEZ and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-23.19%
-76.77%
BMEZ
ARKG

Volatility

BMEZ vs. ARKG - Volatility Comparison

The current volatility for BlackRock Health Sciences Trust II (BMEZ) is 7.90%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 15.22%. This indicates that BMEZ experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
7.90%
15.22%
BMEZ
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab